Identifying Diet-Treatable Diseases

Scientists test which mutations underlie metabolic diseases that may benefit from changes in diet.

Written bySabrina Richards
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

CLIX / STOCK.XCHNG

Scientists have classified which alleles of a mutated enzyme can benefit from changes in diet, in a new yeast study published last week (April 1) in Genetics. Mutations in the cystathionine-ß-synthase (CBS) enzyme can lead to a variety of diseases, such as mental retardation and homocystinuria. Some patients benefit from supplementing their diet with vitamin B6, a cofactor that aids CBS’s enzymatic activity, but it depends on which mutation they carry.

To identify the CBS mutations whose resulting diseases could be aided by diet, scientists from the University of California, Berkeley, expressed different alleles of the human CBS gene in yeast that were missing the CBS ortholog Cys4p. They then measured yeast growth and enzyme activity with and without vitamin B6 or heme, another CBS ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies